The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy.

Moreno, J; Nieto, J; Chamizo, C; González, F; Blanco, F; Barker, D C; Alvar, J

Moreno, J; Nieto, J; Chamizo, C; González, F; Blanco, F; Barker, D C; Alvar, J.

Affiliation

Moreno J; WHO Collaborating Centre for Leishmaniasis, Research Unit for Tropical Diseases and International Health, Centro Nacional de Microbiología, Instituto de Carlos III, Ctra. Majadahonda-Pozuelo, Madrid, Spain.

Vet Immunol Immunopathol ; 71(3-4): 181-95, 1999 Nov 30.

Article in En | MEDLINE | ID: mdl-10587300

Subject(s)

Dog Diseases/immunology; Leishmaniasis, Visceral/veterinary; Leukocytes, Mononuclear/immunology; Amphotericin B/therapeutic use; Animals; Dog Diseases/drug therapy; Dogs; Female; Immune Tolerance; Leishmaniasis, Visceral/drug therapy; Leishmaniasis, Visceral/immunology; Male; Receptors, Antigen, T-Cell, gamma-delta/analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukocytes, Mononuclear / Dog Diseases / Leishmaniasis, Visceral Limits: Animals Language: En Journal: Vet Immunol Immunopathol Year: 1999 Type: Article Affiliation country: Spain

Search on Google

XML

PubMed Links